P05.07 Effect of Tumor-Treating Fields plus Short-Course Radiation with or without Temozolomide in Elderly Patients with Glioblastoma (GERAS Trial)

BACKGROUND: Despite advances in the therapy of glioblastomas (GBM) in the last decades, the most common malignancy of glial origin is still associated with poor prognosis. At present, maximal safe resection followed by adjuvant chemoradiotherapy (CRT) with temozolomide (TMZ) is the standard of care....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Höne, S J, Krisam, J, Jäkel, C, Schmitt, D, Lang, K, El Shafie, R, Adeberg, S, Unterberg, A, Rieken, S, Kieser, M, Debus, J, Bernhardt, D
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Poster Presentations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796028/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.121
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky